PMID- 19740313 OWN - NLM STAT- MEDLINE DCOM- 20100125 LR - 20221207 IS - 1365-2567 (Electronic) IS - 0019-2805 (Print) IS - 0019-2805 (Linking) VI - 128 IP - 1 Suppl DP - 2009 Sep TI - Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. PG - e523-31 LID - 10.1111/j.1365-2567.2008.03022.x [doi] AB - Enteric infections remain a major health problem causing millions of deaths in developing countries. The interplay among the host intestinal epithelium, the mucosa-associated immune system and microbiota performs an essential role in gut homeostasis and protection against infectious diseases. Dendritic cells (DCs) play a key role in orchestrating protective immunity and tolerance in the gut. The mechanisms by which DCs adapt their responses and discriminate between virulent microbes and trillions of innocuous bacteria remain ill-defined. Here we investigated the effect of cross-talk between commensal-related bacteria (CB) and Toll-like receptor (TLR) agonists on DC activation and the outcome of the in vitro T helper response. Human monocyte-derived DCs were exposed to eight different Gram-positive or Gram-negative CB strains prior to activation with five different TLR agonists. The key polarizing cytokines interleukin (IL)-12p70, IL-10, IL-1beta and IL-6 were quantified and the fate of naive T-cell differentiation was evaluated. We identified a unique combination of Lactobacillus casei and TLR3 signals that acted in synergy to selectively increase IL-12p70 secretion. Exposure to poly(I:C) converted L. casei-treated DCs into potent promoters of T helper type 1 (Th1) responses. We propose that DCs can integrate harmless and dangerous non-self signals delivered by viral products, to mount robust Th1 responses. Thus, in vivo DC targeting with selective probiotics may improve strategies for the management of enteric diseases. FAU - Baba, Nobuyasu AU - Baba N AD - Immunoregulation Laboratory, CRCHUM, University of Montreal, Montreal, QC, Canada. FAU - Samson, Sandrine AU - Samson S FAU - Bourdet-Sicard, Raphaelle AU - Bourdet-Sicard R FAU - Rubio, Manuel AU - Rubio M FAU - Sarfati, Marika AU - Sarfati M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20081124 PL - England TA - Immunology JT - Immunology JID - 0374672 RN - 0 (Interferon Inducers) RN - 0 (Interleukin-1beta) RN - 0 (Interleukin-6) RN - 0 (Lipopolysaccharides) RN - 0 (Peptidoglycan) RN - 0 (TLR3 protein, human) RN - 0 (Toll-Like Receptor 3) RN - 12777-81-0 (Flagellin) RN - 130068-27-8 (Interleukin-10) RN - 187348-17-0 (Interleukin-12) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) RN - O84C90HH2L (Poly I-C) SB - IM MH - Dendritic Cells/drug effects/*immunology/microbiology MH - Flagellin/immunology MH - Humans MH - Interferon Inducers/pharmacology MH - Interleukin-10/biosynthesis MH - Interleukin-12/agonists/*biosynthesis/immunology MH - Interleukin-1beta/biosynthesis/immunology MH - Interleukin-6/biosynthesis MH - Intestines/*immunology/microbiology MH - Lacticaseibacillus casei/*immunology MH - Lipopolysaccharides/immunology MH - Peptidoglycan/immunology MH - Poly I-C/pharmacology MH - *Probiotics MH - Signal Transduction/drug effects/immunology MH - Tetradecanoylphorbol Acetate/pharmacology MH - Th1 Cells/drug effects/*immunology/microbiology MH - Toll-Like Receptor 3/*agonists/metabolism PMC - PMC2753912 EDAT- 2009/09/25 06:00 MHDA- 2010/01/26 06:00 PMCR- 2010/09/01 CRDT- 2009/09/11 06:00 PHST- 2009/09/11 06:00 [entrez] PHST- 2009/09/25 06:00 [pubmed] PHST- 2010/01/26 06:00 [medline] PHST- 2010/09/01 00:00 [pmc-release] AID - IMM3022 [pii] AID - 10.1111/j.1365-2567.2008.03022.x [doi] PST - ppublish SO - Immunology. 2009 Sep;128(1 Suppl):e523-31. doi: 10.1111/j.1365-2567.2008.03022.x. Epub 2008 Nov 24.